Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day

About this update from Capricor Therapeutics, Inc.

[{"type":"image","alt":"Capricor Therapeutics","displaySize":"","headline":null,"caption":"Capricor Therapeutics","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":107,"url":"https://media.zenfs.com/en/globenewswire.com/9425e1c34a8f71096412f48bc76eaba7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YaI1GjtfVRH2kLVsjMQa4A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/9425e1c34a8f71096412f48bc76eaba7","width":300,"height":107}},"lazy":false},{"type":"text","content":"SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company will present at the 2025 Piper Sandler Virtual Cardio Day taking place on April 2, 2025.","length":327,"tagName":"p"},{"type":"text","content":"Capricor will take part in a fireside chat to discuss the company’s latest advancements on its lead program of deramiocel for the treatment of Duchenne muscular dystrophy (DMD) as well as provide other general regulatory, scientific and corporate updates.","length":255,"tagName":"p"},{"type":"text","content":"Capricor Therapeutics Fireside Chat ","length":35,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Date: Wednesday, April 2, 2025","length":30,"tagName":"p"}]},{"val":[{"type":"text","content":"Time: 12:00–12:30 p.m. ET","length":25,"tagName":"p"}]},{"val":[{"type":"text","content":"Participants: Linda Marbán, Ph.D., Chief Executive Officer","length":58,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":113,"olType":false},{"type":"text","content":"The Piper Sandler Virtual Cardio Day is an invitation-only event exclusive to Piper Sandler clients. For additional details or to request access to the webcast, please contact your PSC representative.","length":200,"tagName":"p"},{"type":"text","content":"About Capricor Therapeutics","length":27,"tagName":"p"},{"type":"text","content":"Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. At the forefront of our innovation is our lead product candidate, deramiocel, an allogeneic cardiac-derived cell therapy. E...

More updates from Capricor Therapeutics, Inc.